Muscarinic type 2 receptors in the lateral dorsal tegmental area modulate cocaine and food seeking behavior in rats.
- Authors
- Shabani, S; Foster, R; Gubner, N; Phillips, T J; Mark, G P
- Year
- 2010
- Journal
- Neuroscience
- PMID
- 20667466
- DOI
- 10.1016/j.neuroscience.2010.07.028
- PMCID
- PMC2936824
The cholinergic input from the lateral dorsal tegmental area (LDTg) modulates the dopamine cells of the ventral tegmental area (VTA) and plays an important role in cocaine taking. Specific pharmacological agents that block or stimulate muscarinic receptors in the LDTg change acetylcholine (ACh) levels in the VTA. Furthermore, manipulations of cholinergic input in the VTA can change cocaine taking. In the current study, the ACh output from the LDTg was attenuated by treatment with the selective muscarinic type 2 (M2) autoreceptor agonist oxotremorine.sesquifumarate (OxoSQ). We hypothesized that OxoSQ would reduce the motivation of rats to self-administer both natural and drug rewards. Animals were tested on progressive ratio (PR) schedules of reinforcement for food pellets and cocaine. On test days, animals on food and on cocaine schedules were bilaterally microinjected prior to the test. Rats received either LDTg OxoSQ infusions or LDTg artificial cerebrospinal fluid (aCSF) infusions in a within-subjects design. In addition, infusions were delivered into a dorsal brain area above the LDTg as an anatomical control region. OxoSQ microinjection in the LDTg, compared to aCSF, significantly reduced both the number of self-administered pellets and cocaine infusions during the initial half of the session; this reduction was dose-dependent. OxoSQ microinjections into the area just dorsal to the LDTg had no significant effect on self-administration of food pellets or cocaine. Animals were also tested in locomotor activity chambers for motor effects following the above microinjections. Locomotor activity was mildly increased by OxoSQ microinjection into the LDTg during the initial half of the session. Overall, these data suggest that LDTg cholinergic neurons play an important role in modifying the reinforcing value of natural and drug rewards. These effects cannot be attributed to significant alterations of locomotor behavior and are likely accomplished through LDTg muscarinic autoreceptors.
No figures extracted from this document.
| Name | Type |
|---|---|
| Acepromazine | drug |
| acetylcholine | drug |
| ACh | drug |
| acquisition of self-administration behavior local | phenotype |
| aCSF | drug |
| active lever local | anatomy |
| active lever pressing | phenotype |
| alcohol self-administration | phenotype |
| anesthetic cocktail local | drug |
| animals | cohort |
| artificial cerebrospinal fluid | drug |
| behavioral seeking responses local | phenotype |
| brain | anatomy |
| Break point local | phenotype |
| breakpoint (BP) local | phenotype |
| Brevital | drug |
| CaCl2 | drug |
| carbachol | drug |
| CBAS heparin-coated PU catheter local | drug |
| central nucleus of the inferior colliculus local | anatomy |
| Charles River Laboratories local | cohort |
| cholinergic input local | phenotype |
| cholinergic neurons | phenotype |
| cholinomimetics local | drug |
| CHRM2 | gene |
| CHRM4 | gene |
| Chrm5 | gene |
| CIC local | anatomy |
| CIC local | drug |
| cocaine | phenotype |
| cocaine group | cohort |
| Cocaine hydrochloride local | drug |
| cocaine-induced DA levels in NAc local | phenotype |
| cocaine infusion local | phenotype |
| cocaine seeking reinstatement local | phenotype |
| cocaine self-administration | phenotype |
| cocaine study local | cohort |
| Cocaine taking local | phenotype |
| conditioned place preference | phenotype |
| DA | drug |
| DA levels in NAc local | phenotype |
| Dark phase local | phenotype |
| dark phase animals local | cohort |
| dental acrylic local | drug |
| depressive behavior | phenotype |
| depressive-like behaviors local | phenotype |
| dopamine | drug |
| dopamine efflux | drug |
| dopaminergic neurons | anatomy |
| Dopamine transporter | drug |
| drug | drug |
| drug-seeking behavior | phenotype |
| dura | anatomy |
| Escalation of cocaine self-administration local | phenotype |
| fluid | drug |
| Food group local | cohort |
| food pellet | drug |
| food pellet group local | cohort |
| food seeking local | phenotype |
| food self-administration local | phenotype |
| glucose | drug |
| glutamate | drug |
| glutamatergic input local | phenotype |
| guide cannulae local | drug |
| head shields local | drug |
| heparin | drug |
| higher than FR-25 local | phenotype |
| inactive lever local | anatomy |
| inactive lever pressing | phenotype |
| Increased arousal local | phenotype |
| Increased expenditure of time and energy local | phenotype |
| Inwardly rectifying potassium channel local | drug |
| ionotropic glutamate receptor antagonist local | drug |
| IPSP local | phenotype |
| isoflurane | drug |
| Isopentane | drug |
| IV catheter local | drug |
| IV cocaine self-administration training local | phenotype |
| KCl | drug |
| ketamine | drug |
| KH2PO4 local | drug |
| lateral dorsal tegmental area local | anatomy |
| lateral dorsal tegmental nucleus local | anatomy |
| lateral periaqueductal gray local | anatomy |
| laterodorsal tegmental nucleus | anatomy |
| LDTg | anatomy |
| LDTg/PPTg local | anatomy |
| lever pressing local | phenotype |
| Lever pressing local | phenotype |
| lever pressing for cocaine | phenotype |
| lever press ratio local | phenotype |
| light phase animals local | cohort |
| locomotion | phenotype |
| locomotor activity | phenotype |
| locus coeruleus | anatomy |
| loss of control | phenotype |
| M2 antagonist local | drug |
| M2 receptor | drug |
| M2R -/- mice local | cohort |
| M5R +/+ mice local | cohort |
| M5R +/- mice local | cohort |
| M5R -/- mice local | cohort |
| mecamylamine | drug |
| medial prefrontal cortex | anatomy |
| Medial subdivision of LDTg local | anatomy |
| mesocorticolimbic pathway local | anatomy |
| methoctramine local | drug |
| MgCl2 | drug |
| motivated behavior | phenotype |
| motivation for cocaine self-administration local | phenotype |
| Motor ability local | phenotype |
| muscarine local | drug |
| Muscarinic acetylcholine receptor | drug |
| NAc | anatomy |
| NAc DA levels local | phenotype |
| NaHCO3 | drug |
| NaOH | drug |
| neostigmine local | drug |
| nicotine | drug |
| nicotinic acetylcholine receptor | drug |
| Noyes food pellets local | drug |
| nucleus accumbens | anatomy |
| nucleus accumbens shell | anatomy |
| OxoSQ local | drug |
| OxoSQ 10 nmol local | drug |
| Oxotremorine sesquifumarate local | drug |
| pedunculopontine nucleus local | anatomy |
| PPTg | anatomy |
| PR behavior local | phenotype |
| rats | cohort |
| Reinforcing properties | phenotype |
| reward | phenotype |
| rewarding effects of cocaine | phenotype |
| Reward seeking behavior local | phenotype |
| reward seeking behaviors local | phenotype |
| saline | drug |
| scopolamine | drug |
| self-administration of cocaine local | phenotype |
| Silica local | drug |
| SLC6A3 | gene |
| Sprague-Dawley rats | cohort |
| stainless steel screws local | drug |
| tether local | drug |
| Thionin | drug |
| ticarcillin local | drug |
| Ticarcillin local | drug |
| Timentin local | drug |
| ventral tegmental area | anatomy |
| VTA | anatomy |
| VTA dopaminergic neurons local | anatomy |
| water | drug |
| xylazine | drug |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Exploring the efficacy of cholinergic agents for the treatment of psychostimulant use disorder: a systematic review. | Salloum N et al. | — | 2024 | → |
| The mesopontine tegmentum in reward and aversion: From cellular heterogeneity to behaviour. | Bastos-Gonçalves R et al. | — | 2024 | → |
| GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA. | Hernandez NS et al. | — | 2021 | → |
| Central muscarinic receptor subtypes (M1 and M3) involved in carbacol-induced hypophagia in neonatal broiler chicken. | Zendehdel M et al. | — | 2020 | → |
| Cholinergic system in sleep regulation of emotion and motivation. | Mu P et al. | — | 2019 | → |
| Computational Systems Pharmacology-Target Mapping for Fentanyl-Laced Cocaine Overdose. | Cheng J et al. | — | 2019 | → |
| Self-administration of the synthetic cathinone MDPV enhances reward function via a nicotinic receptor dependent mechanism. | Geste JR et al. | — | 2018 | → |
| The rostromedial zona incerta is involved in attentional processes while adjacent LHA responds to arousal: c-Fos and anatomical evidence. | Chometton S et al. | — | 2017 | → |
| Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior. | Bojanowska E et al. | — | 2016 | → |
| A role for the lateral dorsal tegmentum in memory and decision neural circuitry. | Redila V et al. | — | 2015 | → |
| The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior induced by cues or heroin priming in rats. | Lai M et al. | — | 2014 | → |
| The role of the laterodorsal tegmental nucleus in methamphetamine conditioned place preference and locomotor activity. | Dobbs LK et al. | — | 2014 | → |
| Genetic and neurophysiological correlates of the age of onset of alcohol use disorders in adolescents and young adults. | Chorlian DB et al. | — | 2013 | → |
| Contribution of both M1 and M4 receptors to muscarinic agonist-mediated attenuation of the cocaine discriminative stimulus in mice. | Thomsen M et al. | — | 2012 | → |
| Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats. | Liu H et al. | — | 2012 | → |
| Cholinergic modulation of mesolimbic dopamine function and reward. | Mark GP et al. | — | 2011 | → |
| Neural Changes Developed during the Extinction of Cocaine Self-Administration Behavior. | Higuera-Matas A et al. | — | 2011 | → |